Trials / Completed
CompletedNCT04212364
An Evaluation of a Social Network Intervention for Primary and Secondary Prevention of Opioid Overdoses
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 614 (actual)
- Sponsor
- Johns Hopkins Bloomberg School of Public Health · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to pilot and implement a peer mentor intervention focused on overdose prevention and care. The intervention consists of 3 sessions. During the first and second session, each participant will meet individually with a trained staff member. In the 3rd session, the participant will invite a social network member to attend the session, and these 2 participants will meet with a trained staff member.
Detailed description
The specific aims of the study are: 1. Conduct a pilot of an HIV/HCV/overdose prevention and care intervention for people who use opiates. 2. Evaluate the feasibility of collecting donated drug preparation containers (i.e., cookers) to assess the presence of fentanyl, HCV, and HIV. 3. Conduct a randomized controlled trial to assess efficacy of the experimental Peer Mentor condition on (a) overdose prevention and care education to drug network members, (b) naloxone availability, and (c) drug treatment readiness and entry. There are two types of participants: Index participants and network participants. Both type of participant will currently used opiates. Participants will take part in a baseline visit and up to 3 follow-up visits. Index participants will be randomized into the intervention or control arm of the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Peer Education | In this intervention, people who use opiates will be trained to be peer educators. |
| DRUG | Narcan Nasal Product | All study participants will be trained in how to use nasal Narcan and they will receive a nasal Narcan kit. |
Timeline
- Start date
- 2019-03-15
- Primary completion
- 2023-12-29
- Completion
- 2023-12-31
- First posted
- 2019-12-27
- Last updated
- 2024-01-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04212364. Inclusion in this directory is not an endorsement.